VALLEY NATIONAL ADVISERS INC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 208 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
VALLEY NATIONAL ADVISERS INC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$1,00030.0%0.00%
Q4 2020$030.0%0.00%
Q3 2020$030.0%0.00%
Q2 2020$030.0%0.00%
Q1 2020$030.0%0.00%
Q4 2019$030.0%0.00%
Q3 2019$0
-100.0%
30.0%0.00%
Q2 2019$1,0000.0%30.0%0.00%
Q1 2019$1,00030.0%0.00%
Q4 2018$0
-100.0%
30.0%0.00%
Q3 2018$1,00030.0%0.00%
Q2 2018$030.0%0.00%
Q1 2018$030.0%0.00%
Q4 2017$030.0%0.00%
Q3 2017$030.0%0.00%
Q2 2017$030.0%0.00%
Q1 2017$030.0%0.00%
Q4 2016$030.0%0.00%
Q3 2016$030.0%0.00%
Q2 2016$030.0%0.00%
Q1 2016$030.0%0.00%
Q4 2015$030.0%0.00%
Q3 2015$030.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders